FDA.reportPublic FDA data

caffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet

RxCUI
1001437
RxNorm name
caffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet
Display name
Caffeine/Magnesium salicylate (Oral Pill)
Full name
caffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet
Term type
SCD
Status
Active
Strength
50-162.5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-29 05:58:15

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
caffeine50 MG / 1 EACHcaffeinecaffeine
magnesium salicylate162.5 MG / 1 EACHmagnesium salicylatemagnesium salicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
magnesium salicylate52364

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcaffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet1NAMES
RxNorm Namecaffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDe02a39f9-1c8c-4d38-b394-3f5b7062932c1CODES
RxCUI10014371CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
52389-306-3652389-306Diurex Caffeine, magnesium salicylateKobayashi Healthcare International, Inc.M027
52389-306-4252389-306Diurex Caffeine, magnesium salicylateKobayashi Healthcare International, Inc.M027
52389-306-8452389-306Diurex Caffeine, magnesium salicylateKobayashi Healthcare International, Inc.M027

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02752389-306Diurex Caffeine, magnesium salicylateOTC MONOGRAPH DRUGKobayashi Healthcare International, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 8 matching rows.

NDC11, Source, Active table
NDC11SourceActive
52389006542rxnav_ndcsyes
52389030601rxnav_ndcsyes
52389030602rxnav_ndcsyes
52389030636rxnav_ndcsyes
52389030642rxnav_ndcsyes
52389030684rxnav_ndcsyes
52389030621rxnav_historical
52389030622rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Diurex Water PillsCAFFEINE, MAGNESIUM SALICYLATEKobayashi Healthcare International, Inc.e02a39f9-1c8c-4d38-b394-3f5b7062932c2025-04-10WarningsExact identifier
ndc (package): 52389-306-36
ndc (package): 52389-306-42
ndc (package): 52389-306-84
ndc (product): 52389-306
ndc11 (package): 52389030602
ndc11 (package): 52389030621
ndc11 (package): 52389030601
ndc11 (package): 52389030636
ndc11 (package): 52389030622
ndc11 (package): 52389030684
ndc11 (package): 52389030642
rxcui: 1001437

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e02a39f9-1c8c-4d38-b394-3f5b7062932ccaffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet [PSN] · caffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet [SCD]213Diurex Water Pills20250410

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
e02a39f9-1c8c-4d38-b394-3f5b7062932cDiurex Water PillsKobayashi Healthcare International, Inc.20250410

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD012459SalicylatesCHEMhas_ingredientmagnesium salicylate
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withmagnesium salicylate
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treatmagnesium salicylate
MEDRTD010146PainDISEASEmay_treatmagnesium salicylate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamagnesium salicylate
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008832Decreased Platelet AggregationPEhas_pemagnesium salicylate
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemagnesium salicylate
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH50 MG / 162.5 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESVUID4032233
NAMESPrescribable Synonymcaffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File